Professional Spotlight, 04/02/13
COPD: Learn More. Breathe Better. A Conversation Can Be the First Step
Chronic obstructive pulmonary disease (COPD) is now the third leading cause of death in the United States. According to the latest Behavioral Risk Factor Surveillance System (BRFSS) data, an estimated 15 million Americans have been diagnosed with COPD. Yet, many more may have COPD and remain undiagnosed.
CARDIOVASCULAR EPIDEMIOLOGY DIGITAL FORUM
Guest Contributor Dr. David C. Goff Offers Perspective on the Future of Epidemiology
WORKING GROUP EXECUTIVE SUMMARY
Pulseless Electrical Activity—Definition, Causes, Mechanisms, Management, and Research Priorities for the Next Decade
Pulseless electrical activity (PEA) is recognized as an increasingly significant public health burden, since a greater proportion of out-of-hospital sudden cardiac arrests and resulting deaths have been associated with PEA, compared with ventricular tachycardia and ventricular fibrillation. In general, sudden cardiac arrests are a leading cause of death in adults in the United States, resulting in an estimated 200,000 to 450,000 deaths each year, and accounting for 50 percent of all cardiovascular deaths.
NEWS FROM AN NHLBI-FUNDED INSTITUTION
UAB Researchers Discover Possible Treatment for Incurable Lung Disease
An NHLBI-supported research team at the University of Alabama at Birmingham (UAB) has discovered a new pathway that contributes to idiopathic pulmonary fibrosis, an often fatal lung disease with no cure and no effective treatments. More importantly, they have also found a new potential treatment to block this pathway that leads to fibrosis, or scarring of the lungs.
® COPD Learn More Breathe Better is a trademark of the U.S. Department of Health and Human Services (HHS).
Thank you for subscribing. The NHLBI provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. We would greatly appreciate a quick note at NHLBIinfo@nhlbi.nih.gov to let us know how you use this information and what information you would like to see in future newsletters.
You are receiving this email notification because you gave permission to the NHLBI to send you emails. We will not sell or rent your name and information to any third parties outside of the NHLBI. If you experience any difficulty or have questions, please contact us at NHLBIinfo@nhlbi.nih.gov or call (301) 592-8573, TTY (240) 629-3255.
National Heart, Lung, and Blood Institute
The "Delete Account" link will unsubscribe you from every topic and delete your email address from the system. To unsubscribe from select topics, click on "Manage Subscriptions or Account Preferences."
If you have questions or problems with the subscription service, please contact email@example.com. If you have questions or comments about other NHLBI programs or activities, please contact firstname.lastname@example.org.
Last Updated April 2013